India covid-19 medicines patient India

Covid treatment: DRDO invites bids to transfer technology of 2-DG drug

Reading now: 329
www.livemint.com

2-Deoxy-D- Glucose (2-DG), the Defence Research and Development Organisation (DRDO) has invited Expression of Interest (EoI) for transferring technology to Indian pharmaceutical industries for production.The applications are required to be submitted before 17 June through email. "The EoI submitted by industries will be scrutinised by a Technical Assessment Committee (TAC).

Only up to 15 industries will be given ToT on their capabilities, technical handholding capability of DRDO and on First Come First Served Basis," the EoI document read.

Requirements for the bidders include a drug license to manufacture Active Pharmaceutical Ingredient (API) from Drug Licensing Authorities and WHO GMP (Good Manufacturing Practices) certification, among.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA